Li and coworkers reported that pH-sensitive polymeric nanomaterials loaded with siRNAs targeting TWIST1 in combination with paclitaxel suppressed EMT, reducing tumor growth and metastasis as well as ECM degradation in breast cancer cells and orthotopic mice models [111,112]. This evidence concerns the gene TWIST1 and neoplasm.